BI
Bioasis Technologies Inc.
BIOAF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $11.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.30x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 70.18%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 3,150.25%
Net margin 7,846.50%
Op. margin 12,784.50%
Quality
0 /100
Poor ROIC 621.16%
ROA 130.64%
Asset turnover 0.02x
Debt
54 /100
Moderate Current ratio 0.70x
Int. coverage -5.50x
Net debt/EBITDA -0.05x
Stability
4 /100
Unstable Beta 1.74x
Rev. volatility 376.29%
EPS volatility 324.98%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Deborah Ann Rathjen
Employees
4
Headquarters
New Haven
Upcoming events
02 NOV
Earnings
Upcoming earnings report